Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Jun ‘18 |
|
|---|---|---|---|---|---|
| $66.3M | $115M | $48.8M | 38.2% |
|
|
| $65.9M | $106M | $40.3M | 385% |
|
|
| $65.2M | $186M | $121M | 149% |
|
|
104
BioMarin Pharmaceuticals
BMRN
$10.4B
| $64.8M | $180M | $115M | 42.7% |
|
| $64.7M | $145M | $80.5M | 10.4% |
|
|
| $64.4M | $147M | $82.2M | 49.4% |
|
|
| $62.8M | $1.31B | $1.25B | 139% |
|
|
| $62.5M | $284M | $222M | 177% |
|
|
| $60.5M | $307M | $247M | 79.6% |
|
|
| $59.4M | $177M | $118M | 52.8% |
|
|
111
Jazz Pharmaceuticals
JAZZ
$12.3B
| $58.5M | $117M | $58.7M | 16.1% |
|
| $58.1M | $70M | $11.9M | 86.4% |
|
|
| $56.8M | $180M | $123M | 34.7% |
|
|
| $55.3M | $274M | $219M | 207% |
|
|
| $54.6M | $127M | $72.6M | 102% |
|
|
| $54.6M | $68.9M | $14.3M | 48.1% |
|
|
| $54.5M | $141M | $86.6M | 151% |
|
|
| $54.3M | $78.4M | $24.1M | 72.1% |
|
|
| $53.3M | $261M | $207M | 168% |
|
|
| $53.3M | $79M | $25.7M | 1.63% |
|
|
| $52.6M | $323M | $270M | 20.3% |
|
|
| $51.8M | $53.6M | $1.78M | 30.3% |
|
|
| $51.6M | $84.8M | $33.2M | 62.9% |
|
|
| $51.3M | $136M | $85M | 115% |
|
|
| $50.1M | $161M | $111M | 48.7% |
|